文献速递神经肌肉病

超氧化物歧化酶1基因变异所致肌萎缩侧索硬化:从基因发现到疾病预防

Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention.
PubMed 文献 · Lancet Neurol · 2025-01-01

该综述回顾了1993年发现SOD1基因作为ALS首个遗传病因以来的30年历程,涵盖转基因动物模型、毒性功能获得机制及降低SOD1蛋白的治疗策略,并指出神经丝轻链蛋白作为预测症状转化的易感性/风险生物标志物,开启了以预防临床发病为目标的试验新时代。

要点

  • SOD1基因变异是1993年发现的ALS首个遗传病因,其毒性功能获得机制驱动疾病。
  • 降低SOD1蛋白浓度的治疗策略因SOD1 ALS表型异质性而复杂化。
  • 神经丝轻链蛋白作为预测症状转化的易感性/风险生物标志物,助力预防性试验。

核心结论

  • 从基因发现到基因治疗的30年历程不仅揭示了SOD1 ALS的病理生理,还促进了生物标志物开发,应有助于所有类型ALS的治疗开发。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 1993年发现SOD1基因变异是ALS首个遗传病因,并据此开发了转基因啮齿类动物模型。
  • SOD1 ALS由毒性功能获得突变驱动,表型异质性使降低SOD1蛋白浓度的治疗策略复杂化。
  • 神经丝轻链蛋白被描述为预测症状转化的易感性/风险生物标志物。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pathogenic variants in the superoxide dismutase 1 (SOD1) gene were the first identified genetic cause of amyotrophic lateral sclerosis (ALS), in 1993. This discovery enabled the development of transgenic rodent models for studying the biology of SOD1 ALS. The understanding that SOD1 ALS is driven by a toxic gain-of-function mutation has led to therapeutic strategies that aim to lower concentrations of SOD1 protein, an endeavour that has been complicated by the phenotypic heterogeneity of SOD1 ALS. The successful development of genetically targeted therapies to reduce SOD1 expression, together with a better understanding of pre-symptomatic disease and the discovery of neurofilament light protein as a susceptibility/risk biomarker that predicts phenoconversion, has ushered in a new era of trials that aim to prevent clinically manifest SOD1 ALS. The 30-year journey from gene discovery to gene therapy has not only uncovered the pathophysiology of SOD1 ALS, but has also facilitated the development of biomarkers that should aid therapy development for all forms of ALS.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Benatar M, Robertson J, Andersen PM, et al. Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention. Lancet Neurol. 2025. PMID: 39706636. doi:10.1016/S1474-4422(24)00479-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。